CONFLICT OF INTEREST
ONCOLOGY, RTI, EMD
Matthew H. Taylor: Consulting/advisory board member (honoraria paid to MHT): Bristol Myers Squibb, Eisai Inc., Novartis, Merck, Pfizer, Bayer, Sanofi/Genzyme, Regeneron, Bayer, Array Biopharma, LOXO Oncology, Blueprint Medicines, Immuneonc, Exelixis, Cascade Prodrug. Speakers' bureau (honoraria paid to MHT): Bristol Myers Squibb, Eisai Inc., Blueprint Medicines, Merck. Research Funding (all funding to MHT's institution): Bristol Myers Squibb, Merck Sharp & Dohme Corp., Pharmacyclics, AstraZeneca, Eisai, Incyte, EMD Serono, Novartis, Seattle Genetics, AbbVie, Genentech, Eli Lilly, Roche, Acerta Pharma, Genzyme Corporation, Pfizer.Sophie Leboulleux: Advisory Board: Bayer, Eisai, Lilly; Invited Speaker: Eisai.Yury Panaseykin: Nothing to disclose.Bhavana Konda: Research funding (all funding to institution): Eisai, Merck, Bristol Myers Squibb, Xencor, Eli Lilly & Co.Christelle de La Fouchardiere: Honoraria: Eisai, Roche, Servier, Amgen, Bayer, Pierre Fabre Oncologie, Bristol Myers Squibb; Non‐financial support: Roche, Servier, Amgen, Bayer, Pierre Fabre Oncologie, Bristol Myers Squibb.Brett G.M. Hughes: Advisory Board: MSD, BMS, Roche, Pfizer, AZ, Eisai, Takeda, Sanofi; Grant (Institutional): Amgen.Andrew G. Gianoukakis: Advisory Board: Eisai, Exelixis.Young Joo Park: Consultant (Steering committee): Novartis; Research funding: Lilly.Ilia Romanov: Honoraria: Eisai, Bristol Myers Squibb, Merck Serono.Monika K. Krzyzanowska: Advisory Board: Eisai, Ipsen, Novartis; Research funding: Ipsen, Eisai.Diana Garbinsky is a full‐time employee of RTI Health Solutions.Bintu Sherif is a full‐time employee of RTI Health Solutions.Jie Janice Pan is an employee of Eisai Inc.Terri A. Binder is a former employee of, and current consultant to, Eisai Inc., and an Amgen Inc. shareholder.Nicholas Sauter is an employee of Eisai Inc.Ran Xie is an employee of Eisai Inc.Marcia S. Brose: Consulting/advisory board member (honoraria paid to MSB): Eisai Inc, Novartis, Bayer, Sanofi/Genzyme, LOXO Oncology, Blueprint Medicines, Exelixis; Research Funding (all funding to MSB's institution): Eisai, Novartis, Genentech, Eli Lilly, Roche.